...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.
【24h】

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.

机译:靶向耐药革兰氏阳性细菌的DNA结合配体。第1部分:内部苯并咪唑衍生物。

获取原文
获取原文并翻译 | 示例
           

摘要

Novel DNA minor-groove binding ligands with a promising antibacterial profile are described. Apart from excellent in vitro potency against multiple Gram-positive bacterial strains such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), and penicillin-intermediate Streptococcus pneumoniae (PISP), a small subset of compounds was active against Gram-negative bacteria such as Escherichia coli (E. coli).
机译:描述了具有希望的抗菌谱的新型DNA次要沟槽结合配体。除了对多种革兰氏阳性细菌菌株(例如耐甲氧西林的金黄色葡萄球菌(MRSA),耐万古霉素的粪肠球菌(VRE)和青霉素中间的肺炎链球菌(PISP))具有出色的体外效力外,一小部分化合物具有活性抵抗革兰氏阴性细菌,例如大肠杆菌(E. coli)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号